Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Ellison

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
AAPS Pharmsci|December 14, 2001
Influence of drug release properties of conventional solid dosage forms on the systemic exposure of highly soluble drugsL X Yu, C D Ellison, D P Conner, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell linesZ Yang, P J Faustino, P A Andrews, et al.
Profiles of Drug Substances, Excipients, and Related Methodology|March 5, 2016
Bupropion HydrochlorideS R Khan, R T Berendt, C D Ellison, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Product quality of parenteral vancomycin products in the United StatesS Nambiar, R D Madurawe, S M Zuk, et al.
Toxicologic Pathology|August 26, 1998
An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotypeJ L Weaver, J F Contrera, B A Rosenzweig, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
AAPS Pharmsci|December 14, 2001
Influence of drug release properties of conventional solid dosage forms on the systemic exposure of highly soluble drugsL X Yu, C D Ellison, D P Conner, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell linesZ Yang, P J Faustino, P A Andrews, et al.
Profiles of Drug Substances, Excipients, and Related Methodology|March 5, 2016
Bupropion HydrochlorideS R Khan, R T Berendt, C D Ellison, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Product quality of parenteral vancomycin products in the United StatesS Nambiar, R D Madurawe, S M Zuk, et al.
Toxicologic Pathology|August 26, 1998
An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotypeJ L Weaver, J F Contrera, B A Rosenzweig, et al.
Pageof 1